These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18577812)

  • 1. Effects of increasing particle size of low-density lipoprotein on restenosis after coronary stent implantation.
    Kim JS; Kim MH; Lee BK; Rim SJ; Min PK; Yoon SJ; Kim JH; Rhee JH; Yoon YW; Hong BK; Kwon HM; Kim C
    Circ J; 2008 Jul; 72(7):1059-64. PubMed ID: 18577812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
    Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
    Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.
    Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A
    Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of coronary in-stent restenosis in type 2 diabetic patients is related to elevated serum malondialdehyde-modified low-density lipoprotein.
    Shigematsu S; Takahashi N; Hara M; Yoshimatsu H; Saikawa T
    Circ J; 2007 Nov; 71(11):1697-702. PubMed ID: 17965487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
    Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents.
    Kim JS; Lee SY; Lee JM; Yoon YW; Ahn CM; Kim MH; Min PK; Ko YG; Hong BK; Choi D; Kwon HM; Jang Y; Shim WH
    Coron Artery Dis; 2009 Jan; 20(1):59-63. PubMed ID: 19008765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents.
    Roy P; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Torguson R; Xue Z; Gevorkian N; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2007 Sep; 100(6):965-9. PubMed ID: 17826379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
    Tesche C; De Cecco CN; Vliegenthart R; Duguay TM; Stubenrauch AC; Rosenberg RD; Varga-Szemes A; Bayer RR; Yang J; Ebersberger U; Baquet M; Jochheim D; Hoffmann E; Steinberg DH; Chiaramida SA; Schoepf UJ
    J Cardiovasc Comput Tomogr; 2016; 10(5):377-83. PubMed ID: 27431607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of drug-eluting stents for treating in-stent restenosis of drug-eluting stents (from the Korean DES ISR multicenter registry study [KISS]).
    Ko YG; Kim JS; Kim BK; Choi D; Hong MK; Jeon DW; Yang JY; Ahn YK; Jeong MH; Yu CW; Yun KH; Lim DS; Jang Y;
    Am J Cardiol; 2012 Mar; 109(5):607-13. PubMed ID: 22172241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echolucent carotid plaques predict in-stent restenosis after bare metal stenting in native coronary arteries.
    Kitta Y; Obata JE; Takano H; Nakamura T; Kodama Y; Fujioka D; Saito Y; Kawabata K; Mende A; Kobayashi T; Kugiyama K
    Atherosclerosis; 2008 Mar; 197(1):177-82. PubMed ID: 17466305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic patterns of in-stent restenosis in men and women.
    Trabattoni D; Fabbiocchi F; Montorsi P; Calligaris G; Galli S; Ravagnani P; De Martini S; Teruzzi G; Bartorelli AL
    Ital Heart J; 2005 Feb; 6(2):138-42. PubMed ID: 15819507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
    Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
    Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
    Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
    Watanabe Y; Takagi K; Naganuma T; Kawamoto H; Fujino Y; Ishiguro H; Tahara S; Kurita N; Hosawa K; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Aug; 240():108-113. PubMed ID: 28476515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated sirolimus-eluting stent implantation to treat sirolimus-eluting stent and bare-metal stent restenosis.
    Nishihira K; Shibata Y; Ishikawa T; Nomura K; Nakama T; Mine D; Inoue Y; Ashikaga K; Kuriyama N; Matsuyama A; Imamura T; Asada Y; Kitamura K
    Circ J; 2010 Nov; 74(11):2329-33. PubMed ID: 20890050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and classification of neointimal proliferation and in-stent restenosis in post-stenting patients at 1-year interval: findings from non-invasive coronary computed tomography angiography.
    Xu N; Zhang J; Li M; Pan J; Lu Z
    Eur J Radiol; 2014 Oct; 83(10):1816-21. PubMed ID: 25112673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease.
    Takamiya Y; Miura S; Kawamura A; Tanigawa H; Zhang B; Iwata A; Nishikawa H; Matsuo K; Shirai K; Saku K
    Coron Artery Dis; 2009 Jun; 20(4):288-94. PubMed ID: 19440067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of measuring coronary lumen density with multi-slice computed tomography to detect in-stent restenosis.
    Kitagawa T; Yamamoto H; Horiguchi J; Hirai N; Fujii T; Ito K; Kohno N
    Int J Cardiol; 2008 Feb; 124(2):239-43. PubMed ID: 17360050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.